Patents by Inventor Robert F. Devlin

Robert F. Devlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080188007
    Abstract: A fluorescent single chain antibody construct is provided comprising a single chain antibody reactive with a target analyte and conjugated with a fluorophore. Also provided is a method for rapid and accurate detection of analytes using the fluorescent single chain antibody construct thereof. Further provided is a diagnostic kit for detecting pathogens using a fluorescent single chain antibody construct comprising a single chain antibody reactive with pathogen-related antigens and conjugated with a fluorophore.
    Type: Application
    Filed: February 6, 2007
    Publication date: August 7, 2008
    Inventors: K. John Morrow, Xiaokang Deng, Robert F. Devlin, Preston H. Dorsett
  • Patent number: 6872396
    Abstract: This invention particularly discloses an improved immunoassay method for the specific detection of anti-rubella IgM antibodies. This method employs rubella antigens comprising rubella E1 and E2 envelope glycoproteins substantially free of capsid protein. Use of this antigen composition reduces or eliminates nonspecific protein-protein interactions leading to false positive results. A sample diluent comprising urea can also be used in the process to further reduce the occurrence of nonspecific protein-protein interactions. A diagnostic kit to aid in the detection of anti-rubella IgM antibodies is also disclosed.
    Type: Grant
    Filed: October 29, 2003
    Date of Patent: March 29, 2005
    Assignee: Viral Antigens, Inc.
    Inventors: Preston H. Dorsett, Frances I. Byrd, Robert F. Devlin
  • Publication number: 20040096824
    Abstract: This invention particularly discloses an improved immunoassay method for the specific detection of anti-rubella IgM antibodies. This method employs rubella antigens comprising rubella E1 and E2 envelope glycoproteins substantially free of capsid protein. Use of this antigen composition reduces or eliminates nonspecific protein-protein interactions leading to false positive results. A sample diluent comprising urea can also be used in the process to further reduce the occurrence of nonspecific protein-protein interactions. A diagnostic kit to aid in the detection of anti-rubella IgM antibodies is also disclosed.
    Type: Application
    Filed: October 29, 2003
    Publication date: May 20, 2004
    Applicant: VIRAL ANTIGENTS, INC.
    Inventors: Preston H. Dorsett, Frances I. Byrd, Robert F. Devlin
  • Patent number: 6670117
    Abstract: This invention particularly discloses an improved immunoassay method for the specific detection of anti-rubella IgM antibodies. This method employs rubella antigens comprising rubella E1 and E2 envelope glycoproteins substantially free of capsid protein. Use of this antigen composition reduces or eliminates nonspecific protein-protein interactions leading to false positive results. A sample diluent comprising urea can also be used in the process to further reduce the occurrence of nonspecific protein-protein interactions. A diagnostic kit to aid in the detection of anti-rubella IgM antibodies is also disclosed.
    Type: Grant
    Filed: May 7, 2001
    Date of Patent: December 30, 2003
    Assignee: Viral Antigens, Inc.
    Inventors: Preston H. Dorsett, Frances I. Byrd, Robert F. Devlin
  • Publication number: 20010055757
    Abstract: This invention particularly discloses an improved immunoassay method for the specific detection of anti-rubella IgM antibodies. This method employs rubella antigens comprising rubella E1 and E2 envelope glycoproteins substantially free of capsid protein. Use of this antigen composition reduces or eliminates nonspecific protein-protein interactions leading to false positive results. A sample diluent comprising urea can also be used in the process to further reduce the occurrence of nonspecific protein-protein interactions. A diagnostic kit to aid in the detection of anti-rubella IgM antibodies is also disclosed.
    Type: Application
    Filed: May 7, 2001
    Publication date: December 27, 2001
    Applicant: VIRAL ANTIGENS, INC.
    Inventors: Preston H. Dorsett, Frances I. Byrd, Robert F. Devlin
  • Patent number: 5846703
    Abstract: Fluorescence immunoassays methods are provided which use fluorescent dyes which are free of aggregation and serum binding. Such immunoassay methods are thus, particularly useful for the assay of biological fluids, such as serum, plasma, whole blood and urine.
    Type: Grant
    Filed: March 23, 1993
    Date of Patent: December 8, 1998
    Assignee: Diatron Corporation
    Inventors: Robert F. Devlin, Walter B. Dandliker, Peter O. G. Arrhenius
  • Patent number: 5707813
    Abstract: The present invention is directed to compositions comprising an oligonucleotide linked to a detectably labeled marker component comprising a fluorophore moiety which comprises a substantially planar, multidentate macrocyclic ligand coordinated to a central atom capable of coordinating with two axial ligands and two polyoxyhydrocarbyl moieties which are attached as axial ligands to the central atom. The present invention is also directed to nucleic acid hybridization and amplification methods employing such compositions.
    Type: Grant
    Filed: September 6, 1996
    Date of Patent: January 13, 1998
    Assignee: Diatron Corporation
    Inventors: Walter B. Dandliker, Robert F. Devlin
  • Patent number: 5606045
    Abstract: The present invention is directed to compositions comprising an oligonucleotide linked to a detectably labeled marker component comprising a fluorophore moiety which comprises a substantially planar, multidentate macrocyclic ligand coordinated to a central atom capable of coordinating with two axial ligands and two polyoxyhydrocarbyl moieties which are attached as axial ligands to the central atom. The present invention is also directed to nucleic acid hybridization and amplification methods employing such compositions.
    Type: Grant
    Filed: April 21, 1993
    Date of Patent: February 25, 1997
    Assignee: Diatron Corporation
    Inventors: Walter B. Dandliker, Robert F. Devlin